期刊文献+

盐酸安非他酮与盐酸氟西汀治疗抑郁症的临床研究 被引量:2

下载PDF
导出
摘要 目的比较安非他酮与氟西汀对抑郁症的疗效和安全性。方法将125例抑郁症患者随机分为两组,研究组口服安非他酮治疗,对照组口服氟西汀治疗,均6周一个疗程。研究组63例,男30例,女33例;平均年龄(38.8±12.4)岁,平均病程(15.5±4.9)个月,予安非他酮300~450mg/d,po,tid。对照组62例,男28例,女34例;平均年龄(35.9±11.1)岁,平均病程(14.9±8.6)个月,予氟西汀20~40mg/d,po,qd。结果对抑郁症的治疗,安非他酮组显效率71%,氟西汀组为74%,两组间疗效比较无显著性差异(P>0.05);对伴随焦虑症状的治疗,安非他酮组显效率48%,氟西汀组显效率45%,两组比较无显著性差异(P>0.05)。两组不良反应发生率均较低,且程度较轻微。结论安非他酮与帕罗西汀治疗抑郁症总体疗效相当,能有效治疗抑郁及伴随焦虑症状,且安全性高。
出处 《中国医药指南》 2011年第33期120-121,共2页 Guide of China Medicine
  • 相关文献

参考文献9

  • 1Golden RN,Rvdorfer MV,Sherer MA,et al.Bupropion in depression.I.Biochemical effects and clinical response[J].Arch Gen Psychia-try,1988,45(2):139-143.
  • 2Tomarken AJ,Dichter GS,Freid C,et al.Assessing the effects of bupropion SR on mood dinensions of depression[J].J Affect Disord,2004,78(3):235-241.
  • 3Lam RW,Hossie H,Solomons K,et al.Citalopram and bupropion-SR:combining versus switching in patients with treatment-resist-ant depression[J].J Clin Psychiatry,2004,65(3):337-340.
  • 4Croft H,Houser TL,Jamerson BD,et al.Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks[J].Clin Ther,2002,24(4):662-672.
  • 5Weihs KL,Houser TL,Batey SR,et al.Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression[J].Biol Psychiatry,2002,51(9):753-761.
  • 6Nieuwstraten CE,Dolovich LR.Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression[J].Ann Pharmaco-ther,2001,35(12):1608-1613.
  • 7李华芳,赵靖平,况伟宏,姚培芬,陈晋东,孙学礼,顾牛范.安非他酮缓释片治疗抑郁症72例的随机双盲双模拟多中心临床研究[J].中国新药与临床杂志,2005,24(8):614-618. 被引量:14
  • 8李冠军,李华芳,沈晓玲,殷美莉,周自强.盐酸安非他酮缓释片治疗抑郁症的随机、双盲、双模拟平行对照研究[J].上海精神医学,2005,17(3):160-162. 被引量:10
  • 9Settle EC,Stahl SM,Batey SR,et al.Safety profile of sustained-release bupropion in depression:results of three clinical trials[J].Clin Ther,1999,21(3):454-463.

二级参考文献18

  • 1Tomarken AJ, Dichter GS, Freid C, et.al. Assessing the effects of bupropion SR on mood dimensions of depression. J Affect Disord, 2004, 78(3): 235-241.
  • 2Glod CA, Lynch A, Flynn E, et.al. Open trial of bupropion SR in adolescent major depression. J Child Adolesc Psychiatr Nurs, 2003, 16(3): 123-130.
  • 3Jamerson BD, Krishnan KR, Roberts J, et.al. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. Psychopharmacol Bull, 2003, 37(2): 67-78.
  • 4Settle EC, Stahl SM, Batey SR, et,al. Safety profile of sustained-release bupropion in depression: results of three clinical trials. Clin Ther, 1999, 21(3): 454-463.
  • 5LAM RW, HOSSIE H, SOLOMONS K, et al. Citalopram and bupropion-SR: combining versus switching in patients with treatmentresistant depression [J]. J Clin Psychiatry, 2004, 65(3):337-340.
  • 6CROFT H, HOUSER TL,JAMERSON BD, et al. Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks [J]. Clin Ther, 2002, 24(4): 662-672.
  • 7VULINK NC, DENYS D, WESTENBERG HG. Bupropion for patients with obsessive-compulsive disorder: an open-label, fixeddose study [J]. J Clin Psychiatry, 2005,66 (2) :228-230.
  • 8DUNNER DL, KWONG WJ, HOUSER TL, et al. Improved health-related quality of life and reduced productivity loss after treatment with bupropion sustained release: a study in patients with major depression [J]. Prim Care Companion J Clin Psychiatry,2001, 3(1) :10-16.
  • 9WEIHS KL, HOUSER TL, BATEY SR, et al. Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression [J]. Biol Psychiatry, 2002, 51 (9): 753-761.
  • 10TOMARKEN AJ, DICHTER GS, FREID C, et al. Assessing the effects of bupropion SR on mood dimensions of depression [J]. JAffect Disord, 2004, 78(3): 235-241.

共引文献18

同被引文献34

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部